文献速递自身炎症与 IgG4 相关病

自身炎症综合征的挑战:聚焦高IgD综合征

The challenge of autoinflammatory syndromes: with an emphasis on hyper-IgD syndrome.
PubMed 文献 · Rheumatology (Oxford) · 2016-01-01

自身炎症综合征是缺乏适当触发因素时出现过度炎症反应的疾病,临床表型部分重叠但各有差异。近年多数遗传基础已阐明,遗传缺陷导致炎症介质产生增强或先天免疫抑制不足,其中IL-1β突出,IL-1阻断剂治疗获显著临床效果。本文基于30年经验详细讨论高IgD综合征。

要点

  • 自身炎症综合征以反复发热和急性期反应为特征,遗传缺陷致IL-1β等炎症介质失调。
  • IL-1受体拮抗剂(anakinra)和抗IL-1β单抗等靶向治疗取得显著临床效果。
  • 高IgD综合征(甲羟戊酸激酶缺乏症)是本文重点讨论的自身炎症综合征之一。

核心结论

  • 自身炎症综合征的遗传缺陷导致炎症介质产生增强或先天免疫抑制不足,IL-1β是核心失调因子。
  • 靶向阻断IL-1通路的治疗(如anakinra和抗IL-1β单抗)在自身炎症综合征中取得显著临床效果。

研究设计与样本

  • 本文为基于30年高IgD综合征诊治经验的综述性文章。

主要发现

  • 原型自身炎症综合征包括FMF、高IgD综合征(甲羟戊酸激酶缺乏症)、TNF受体相关周期性综合征和冷吡啉相关周期性综合征。
  • 各综合征临床表型部分重叠(发热、急性期反应),但在发热模式、发作性vs慢性炎症及伴随体征上存在差异。
  • 许多相对罕见且多为遗传性的自身炎症综合征的遗传基础已被阐明。
  • IL-1β是失调炎症介质中的突出促炎细胞因子。

临床怎么用

  • 对疑似自身炎症综合征患者应识别发热模式和伴随体征,并考虑遗传学检测。
  • IL-1阻断剂(如anakinra和抗IL-1β单抗)是自身炎症综合征的有效靶向治疗选择。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Autoinflammatory syndromes are disorders with an exaggerated inflammatory response, mostly in the absence of an appropriate trigger. Prototypic autoinflammatory syndromes are FMF, hyper-IgD syndrome (also known as mevalonate kinase deficiency), TNF receptor-associated periodic syndrome and cryopyrin-associated periodic syndrome. The clinical phenotypes partly overlap (with fever and acute phase response), but also differ between the various syndromes (e.g. regarding fever pattern, episodic vs chronic inflammation and accompanying clinical signs). In recent years, the genetic basis of quite a number of these relatively rare and mostly hereditary disorders has been elucidated. These genetic defects lead to either enhanced production of inflammatory mediators or to a lack of inhibition of these components of the innate immune system. Among these dysregulated inflammatory mediators, the pro-inflammatory cytokine IL-1β stands out. Hence, targeted treatment with blockers of IL-1 action, such as recombinant IL-1 receptor antagonist (IL-1Ra, anakinra) and mAb against IL-1β has met with impressive clinical results. In this article, hyper-IgD syndrome is discussed in more detail, based on 30 years of experience with this syndrome.

来源:Rheumatology (Oxford),查看原文。版权归原作者所有。

引用

  1. van der Meer JW, Simon A. The challenge of autoinflammatory syndromes: with an emphasis on hyper-IgD syndrome. Rheumatology (Oxford). 2016. PMID: 27856657

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。